Pharmaceutical intermediates, which can be used to prepare substituted imidazole derivatives with the following structure, which have high-efficiency KDM1A enzyme inhibitory activity and more than monoamine oxidase (MAO) selectivity, and can be used for histone demethylase activity Prevention or treatment of related diseases and disorders.
Reviews
There are no reviews yet.